Purification of glomerulopressin.
The present investigation was undertaken to attempt the purification of glomerulopressin. Isolated rat livers were perfused with Krebs-Ringer bicarbonate, and the perfusate was concentrated at reduced pressure, extracted with n-butanol, and subjected to thin-layer chromatography (TLC) with different solvent systems. For monodimensional TLC, (a) acetic acid or (b) chloroform/methanol/formic acid (65:30:5, v/v) was used. For bidimensional TLC solvent (b) was used as the first mobile phase and as the second mobile phase three different solvent systems were employed as follows: ethyl acetate/n-butanol/formic acid (40:57:3; v/v), pyridine/methanol/formic acid (50:49:1, v/v), and acetic acid/n-butanol/water (5:50:10, v/v). The activity of the spots viewed under uv light was studied in three different biological assays: increase of the glomerular pressure index (GPI) in the toad and of the glomerular filtration rate (GFR) in the rat and increase of the tonic tension contraction in the rat stomach strip (TTC). In monodimensional TLC developed with system (a), three spots were detected, and with system (b), seven spots were observed. The biological activity of these seven spots was studied. Only the substance showing Rf 0.47 was active. This Rf 0.47 spot subjected to bidimensional TLC with the three different solvent systems moved in the second direction as only one spot. To confirm whether the Rf 0.47 spot was composed by only one substance, reverse-phase HPLC was performed in a Waters radial compression unit using three different elution systems and in a Hewlett-Packard model equipped with an ultrasphere ODS column. With these different HPLC columns and elution systems, only one peak was observed. This is the first attempt to purify a substance showing a biological activity similar to that of glomerulopressin.